SAM
MD icon

Senzar Asset Management’s Pediatrix Medical MD Stock Holding History

Senzar Asset Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-153,000
Closed -$6.6M – 34
2017
Q3 		$6.6M Buy
+153,000
New +$7.27M 1.61% 20

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Senzar Asset Management's MD Position: Q4 2017 in Review

Senzar Asset Management sold out of Pediatrix Medical (MD) in Q4 2017, closing a stake of 153,000 shares — an estimated $6.6M sold.

Senzar Asset Management first reported a position in MD in Q3 2017 and held it in 1 quarter. The position peaked at $6.6M in Q3 2017. 330 funds tracked by Wall St. Rank hold MD as of Q4 2017.

  • Senzar Asset Management reported no remaining Pediatrix Medical position as of Q4 2017 after selling out during the quarter.
  • Senzar Asset Management sold 153,000 Pediatrix Medical shares in Q4 2017, an estimated $6.6M.
  • Senzar Asset Management first reported a position in Pediatrix Medical in Q3 2017 and held it in 1 quarter.
  • Senzar Asset Management's Pediatrix Medical position peaked at $6.6M in Q3 2017.
  • 330 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2017.

Based on Senzar Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.